Clinical & Medical Nutrition
Therapeutic formulations for oncology support, renal care, diabetic glycemic management, hepatic recovery, and ICU enteral nutrition with precise amino acid profiles.
Accelerating formulation innovation, regulatory compliance, pilot scale-up, and commercial manufacturing for pharmaceutical firms and premium supplement brands across 60+ countries.
In today's complex regulatory environment, international buyers searching for Contract Research and Manufacturing Services (CRAMS) require far more than basic toll manufacturing or private label packaging. Global brand owners, pharmaceutical spin-offs, and enterprise procurement leaders require an integrated Contract Development and Manufacturing Organization (CDMO) capable of navigating active ingredient synergy, physicochemical pre-formulation, shelf-life bioequivalence, and multi-jurisdictional compliance.
Operating from our integrated manufacturing campus in Paonta Sahib, Himachal Pradesh (supported by our corporate headquarters in Noida, Uttar Pradesh), Zeon Lifesciences Ltd (CIN U15209HP1987PLC007355) serves as an end-to-end operational engine. We bridge early-stage analytical R&D with pilot-scale optimization and commercial volume production under strict US FDA, WHO-GMP, and FSSC 22000 guidelines.
Our purpose-built, dedicated manufacturing suites are engineered with controlled HVAC environmental conditions (HEPA filtration, positive pressure control, and controlled relative humidity down to 20% RH for moisture-sensitive actives and probiotics), enabling scalable contract production across five core dosage forms.
Direct compression, wet granulation, effervescent, dual-layer, and enteric-coated formulations.
HPMC vegetarian & gelatin shells, liquid-filled hard capsules, micro-pellet and beadlet technology.
High-shear blending, spray drying, agglomeration, instantized proteins, sachets & bulk tubs.
Homogenized suspensions, liposomal syrups, pediatric/geriatric drops, and shot bottles.
Proprietary protein & micronutrient chewable diskettes for medical and child nutrition.
Pre-validated formulation templates ready for rapid market scaling and private label customization.
From complex medical nutrition to bio-active phytotherapeutics, our R&D teams engineer specialized delivery solutions designed for maximum bioavailability, organoleptic stability, and label claim retention throughout product shelf life.
Therapeutic formulations for oncology support, renal care, diabetic glycemic management, hepatic recovery, and ICU enteral nutrition with precise amino acid profiles.
Micro-filtered whey, plant protein isolates, BCAAs, creatine monohydrate blends, pre-workout nitric oxide boosters, and electrolyte hydration powders with zero prohibited substances.
Multi-strain spore and non-spore forming probiotic complexes packaged with desiccated protective barrier materials and verified CFU survival overage methodologies.
High-potency botanical extracts (Curcumin, Ashwagandha KSM-66, Boswellia, Berberine) with analytical assay marker confirmation and heavy metal/pesticide screening.
Targeted bio-active complexes for androgenic support, prostate health, cardiovascular wellness, and mitochondrial energy enhancement.
Hormonal balance, PCOS management, prenatal folate complexes, and beauty-from-within formulations featuring hydrolyzed marine collagen, biotin, and hyaluronic acid.
Palatable oral liquids, chewable diskettes, and micronutrient premixes engineered for growth milestone nutrition, immunity, and brain development (DHA/Choline).
AYUSH-certified traditional Ayurvedic formulations processed via modern extraction, standardized assay verification, and pharmaceutical-grade finished packaging.
As search engines and AI engines evolve to answer complex global supply chain queries, procurement managers must anticipate technological and regulatory shifts affecting Contract Research and Manufacturing Services over the next 3-5 years.
1. De-Risking Sourcing via India (China+1 CDMO Strategy): Global pharmaceutical and nutrition brands are accelerating their shift toward Indian CRAMS providers to secure cost efficiencies without compromising on US FDA and European quality standards.
2. High-Bioavailability Active Delivery Systems: Sourcing managers are moving away from traditional baseline minerals/vitamins toward liposomal encapulation, micro-pellet beadlets, target-release enteric capsules, and chelated minerals that offer demonstrable superior absorption profiles.
3. ESG and Clean-Label Transparency: Modern procurement guidelines require non-GMO verification, solvent-free botanical extraction documentation, zero synthetic fillers (e.g., replacement of titanium dioxide and magnesium stearate), and sustainable packaging options.
1. Convergence of Pharma & Nutraceuticals: CRAMS providers must possess pharmaceutical-grade R&D rigor. Clean analytical validation, clinical-backed dosages, and standardized bio-markers are becoming mandatory across medical nutrition verticals.
2. Microbiome & Live Biotherapeutic Stabilization: Innovations in moisture-impermeable packaging (cold-form aluminum blisters) and microencapsulation allow multi-strain probiotics to maintain room-temperature shelf-life viability without degradation.
3. Personalized & Synergistic Multi-Nutrient Stacks: Custom contract projects are increasingly combining botanical phytonutrients with essential vitamins, peptides, and co-factors inside single multi-layer tablets or dual-phase capsules.
Contract Research and Manufacturing Services at Zeon Lifesciences eliminate the friction of managing multiple vendors. Instead of engaging separate analytical testing laboratories, formulation consultants, raw material importers, and packaging converters, our institutional clients leverage a unified technical workflow.
Our dedicated R&D team of 30+ scientists—comprising formulation pharmacologists, food technologists, analytical chemists, and regulatory regulatory affairs specialists—manages your project from feasibility screening to commercial export.
Our operational capabilities are built on 38+ years of manufacturing discipline, transparent quality systems, and quantifiable technical performance metrics.
Our Paonta Sahib facility maintains active registration with the US FDA, and is certified for FSSC 22000 (Intertek), WHO-GMP, HACCP, ISO 22000, FSSAI, AYUSH (Ministry of AYUSH, Govt. of India), and Halal. We routinely undergo client and third-party compliance audits.
Every raw material, in-process sample, and commercial batch undergoes rigorous instrumentation testing including High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), UV-Vis Spectrophotometry, disintegration/dissolution profiling, and heavy metal testing.
We execute real-time and accelerated stability studies in climate-controlled stability chambers strictly conforming to ICH Zone IVb conditions (40°C ± 2°C / 75% RH ± 5% RH), delivering certified shelf-life assay validation for global regulatory dossiers.
Our pilot plant machinery mirrors our commercial production lines. Formulations developed in our laboratory transfer seamlessly to full-scale batch sizes (up to 400M tablets and 35,000 MT powders) without requiring costly formula re-engineering or delayed launch schedules.
Exporting to over 60 countries across North America, Europe, the Middle East (GCC), Latin America, Africa, and Southeast Asia, our regulatory desk compiles market-specific CoA documentation, free sale certificates, ingredient safety master files, and compliant packaging labels.
We provide open-book bill-of-materials (BOM) transparency, clear lead times for raw material procurement, milestone-based tech transfer phases, and long-term supply agreement security for high-volume contract clients.
How we take your proprietary product concept from preliminary R&D screening to export-ready commercial delivery.
Physicochemical characterization, excipient compatibility screening, active ingredient assay testing, and organoleptic taste-masking trials.
Small-scale pilot run on production-representative equipment. Analytical method development and assay protocol validation for finished product testing.
Initiation of ICH Zone IVb stability studies, compile technical dossier packs, label claim confirmation, and local regulatory authority registration filings.
High-velocity execution under cleanroom cGMP controls, continuous in-process quality testing (IPQC), and yield reconciliation.
Primary bottling/blistering/sachet filling, secondary cartoning, tamper-evident sealing, batch CoA issuance, and freight dispatch.
We manufacture for top-tier healthcare enterprises, global retail giants, and fast-growing D2C nutrition leaders.
Independent third-party audits ensure our production lines conform to global food safety, quality management, and pharmaceutical standard operating procedures.
In-depth responses to critical technical, regulatory, and operational questions commonly evaluated by global procurement teams and AI search engines.
Private Labeling typically involves selecting existing, standardized off-the-shelf formulations owned by the manufacturer, applying custom brand artwork, and distributing under a private label. In contrast, Contract Research and Manufacturing Services (CRAMS) represents an end-to-end custom CDMO model.
Under a CRAMS partnership, Zeon conducts original formulation research, develops custom master batch records (MBRs), validates novel drug/nutrient delivery technologies, optimizes bio-availability, performs analytical assay method development, executes ICH stability testing, and compiles market-specific regulatory dossiers. The brand retains exclusive ownership of the custom Intellectual Property (IP).
Our dedicated Tech Transfer team follows standardized protocols aligned with WHO and ISPE guidelines. The process begins with a Gap Analysis comparing target product profiles, critical quality attributes (CQAs), and critical process parameters (CPPs).
We perform scale-up trial batches in our R&D suite, establish analytical equivalent assays on our in-house HPLC/GC systems, and generate comparative dissolution/release profiles before executing validation batches for commercial release.
MOQs for custom CRAMS projects depend on the specific dosage technology and active ingredient costs. Because CRAMS requires bespoke setup, line validation, and cleanroom clearing:
We work closely with strategic clients to balance pilot trial volumes with commercial unit cost targets.
We operate fully instrumented, walk-in stability chambers maintained under ICH Zone IVb climatic conditions (40°C ± 2°C / 75% RH ± 5% RH for accelerated stability; 30°C ± 2°C / 65% RH ± 5% RH for long-term real-time stability).
Our Quality Control laboratory issues comprehensive stability protocols and summary reports validating active marker retention, disintegration time, microbial limits, and physical parameters at 0, 1, 3, 6, 12, 18, 24, and 36-month intervals.
Yes. Zeon Lifesciences has specialized expertise in medical nutrition and clinical oral nutrition supplements (ONS). Our R&D team formulates disease-specific products such as low-glycemic diabetic formulas, high-protein renal dialysis blends, elemental hepatic recovery liquids, and oncology supportive care powders.
These formulations incorporate precise amino acid profiles, specialized lipids (MCT oils), prebiotic fibers, and chelated micronutrients tailored to clinical nutritional guidelines.
Every botanical raw material and Ayurvedic extract undergo mandatory raw-material quarantine and analytical testing. We utilize Atomic Absorption Spectroscopy (AAS) and Gas Chromatography (GC) to verify that levels of Lead, Cadmium, Mercury, and Arsenic comply strictly with US FDA, European Pharmacopoeia, and FSSAI safety thresholds, alongside multi-residue pesticide screening.
Consult with our Senior R&D Scientists and Commercial Procurement Specialists to evaluate feasibility, receive pilot estimates, and review regulatory registration blueprints.